DE69507022T2 - Verfahren zur unterscheidung zwischen den varianten des menschlichen immunschwächevirus, die syncytien induzieren, und denen, die keine syncytien induzieren und primers zur verwendung in den verfahren - Google Patents

Verfahren zur unterscheidung zwischen den varianten des menschlichen immunschwächevirus, die syncytien induzieren, und denen, die keine syncytien induzieren und primers zur verwendung in den verfahren

Info

Publication number
DE69507022T2
DE69507022T2 DE69507022T DE69507022T DE69507022T2 DE 69507022 T2 DE69507022 T2 DE 69507022T2 DE 69507022 T DE69507022 T DE 69507022T DE 69507022 T DE69507022 T DE 69507022T DE 69507022 T2 DE69507022 T2 DE 69507022T2
Authority
DE
Germany
Prior art keywords
syncytes
induce
methods
hiv
primers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69507022T
Other languages
English (en)
Other versions
DE69507022D1 (de
Inventor
Ronaldus Adrianus Mar Fouchier
Johanna Schuitemaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Sanquin Bloedvoorziening
Original Assignee
Stichting Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Sanquin Bloedvoorziening filed Critical Stichting Sanquin Bloedvoorziening
Publication of DE69507022D1 publication Critical patent/DE69507022D1/de
Application granted granted Critical
Publication of DE69507022T2 publication Critical patent/DE69507022T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69507022T 1994-04-19 1995-04-19 Verfahren zur unterscheidung zwischen den varianten des menschlichen immunschwächevirus, die syncytien induzieren, und denen, die keine syncytien induzieren und primers zur verwendung in den verfahren Expired - Fee Related DE69507022T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94201076 1994-04-19
PCT/NL1995/000142 WO1995028500A1 (en) 1994-04-19 1995-04-19 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus

Publications (2)

Publication Number Publication Date
DE69507022D1 DE69507022D1 (de) 1999-02-11
DE69507022T2 true DE69507022T2 (de) 1999-06-24

Family

ID=8216813

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69507022T Expired - Fee Related DE69507022T2 (de) 1994-04-19 1995-04-19 Verfahren zur unterscheidung zwischen den varianten des menschlichen immunschwächevirus, die syncytien induzieren, und denen, die keine syncytien induzieren und primers zur verwendung in den verfahren

Country Status (11)

Country Link
US (1) US6379881B1 (de)
EP (1) EP0756639B1 (de)
JP (1) JPH09511905A (de)
AT (1) ATE175244T1 (de)
AU (1) AU694205B2 (de)
CA (1) CA2188317A1 (de)
DE (1) DE69507022T2 (de)
DK (1) DK0756639T3 (de)
ES (1) ES2129199T3 (de)
GR (1) GR3029671T3 (de)
WO (1) WO1995028500A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101921732A (zh) 2001-01-19 2010-12-22 维洛诺瓦蒂夫公司 在易感哺乳动物中引起呼吸道疾病的病毒
WO2003072720A2 (en) 2002-02-21 2003-09-04 Medimmune Vaccines, Inc. Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1284931C (en) * 1986-03-13 1991-06-18 Henry A. Erlich Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
US5604099A (en) * 1986-03-13 1997-02-18 Hoffmann-La Roche Inc. Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
GB8918226D0 (en) * 1989-08-09 1989-09-20 Wellcome Found Dna assays

Also Published As

Publication number Publication date
ES2129199T3 (es) 1999-06-01
JPH09511905A (ja) 1997-12-02
ATE175244T1 (de) 1999-01-15
DE69507022D1 (de) 1999-02-11
GR3029671T3 (en) 1999-06-30
CA2188317A1 (en) 1995-10-26
US6379881B1 (en) 2002-04-30
WO1995028500A1 (en) 1995-10-26
EP0756639B1 (de) 1998-12-30
AU2150095A (en) 1995-11-10
AU694205B2 (en) 1998-07-16
EP0756639A1 (de) 1997-02-05
DK0756639T3 (da) 1999-08-30

Similar Documents

Publication Publication Date Title
ES2118593T3 (es) Analogos de nucleotidos de pteridina como sondas fluorescentes de adn.
Christodoulou et al. Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p
DE69333073D1 (de) Verwendungen von fluoreszierenden n-nukleosiden und dessen analogen
Otsuki et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies
Holmdahl et al. Rapid and sensitive identification of Neospora caninum by in vitro amplification of the internal transcribed spacer 1
PT81156B (pt) Processo para a preparacao de uma sonda para a deteccao do adn de umvirus de linfadenocitos
ATE280226T1 (de) Genetische marker für brust und eierstockkrebs
DE60038993D1 (de) Oligonukleotidprimer zur reversen Transkription für den effizienten Nachweis von HIV-1 und HIV-2 und Methoden ihrer Verwendung
DK605987A (da) Bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater
PT979308E (pt) Metodo de preparacao de um padrao tipo de um transcrito genetico para diagnostico
EP0774518A3 (de) Nukleinsäure-Sonden complementär zu Nukleinsäure von humane Papillomavirus, entsprechende Verfahren und Kits
DE3850055T2 (de) Mittel und Verfahren zur Erhöhung der Nukleinsäure-Hybridisierung.
ATE48140T1 (de) Modifizierte nukleotide und verfahren zu ihrer herstellung und anwendung.
DE69507022D1 (de) Verfahren zur unterscheidung zwischen den varianten des menschlichen immunschwächevirus, die syncytien induzieren, und denen, die keine syncytien induzieren und primers zur verwendung in den verfahren
ES2123000T3 (es) Secuencias de adn del papilomavirus hpv 42 y su aplicacion en diagnostico.
ATE329022T1 (de) Verzögerter fortschritt von aids durch missense allel des ccr2 gens
EP2062983A3 (de) Primer und Sonden zum Nachweis genitaler HPV-Genotypen
Borenshtain et al. Marek's disease virus genome separation from feather tip extracts by pulsed field gel electrophoresis
Samoszuk et al. Epstein-Barr virus and interleukin-5 mRNA in acquired immunodeficiency syndrome-related lymphomas with eosinophilia
Mathew et al. Linkage analysis of chromosome 17 markers in British and South African families with neurofibromatosis type 1
Ilyin et al. Type D retrovirus specific sequences in lymphocytes of the children with Burkitt-type lymphoma and their parents
Gabal et al. A polymerase chain reaction ‘PCR’for a quick diagnosis of aspergillosis
Ronai et al. Interaction of SEWA sarcoma cell proteins with the intracisternal A‐type particle long terminal repeat dna sequence
CN105002184A (zh) 一种变异种系scn11a基因在制备诊断芯片中的应用
Cheng Comparing RNA PCR tests

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: STICHTING SANQUIN BLOEDVOORZIENING, AMSTERDAM, NL

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee